ISA Pharmaceuticals announces the start of clinical trial using its novel AMPLIVANT® technology

ISA to present key learnings for cancer vaccine development at the ESMO Immuno-Oncology Congress

ISA Pharmaceuticals Co-authors Publication in Nature Reviews Cancer on Therapeutic Cancer Vaccines

ISA has relocated to brand new Biopartner 5 building

ISA Pharmaceuticals selects product candidate for clinical trial with first in class COVID-19 immunotherapy